Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesis

Area of Science:

• Hematology
• Molecular Biology
• Cancer Research

Background:

• The histone demethylase KDM6B (JMJD3) is implicated in blood disorders.
• Its role in hematopoietic stem cells (HSCs) requires further investigation.

Purpose of the Study:

• To investigate the function of Kdm6b in HSCs.
• To evaluate KDM6B as a potential therapeutic target for hematopoietic malignancies.

Main Methods:

• Analysis of Kdm6b function in adult mice HSCs.
• Gene expression profiling of Kdm6b-deficient HSCs.
• Assessment of Kdm6b's role in T-cell acute lymphoblastic leukemia (T-ALL) and M5 acute myeloid leukemia (AML) models.

Main Results:

• Loss of Kdm6b led to HSC depletion and impaired self-renewal under stress.
• Kdm6b deficiency induced a pro-differentiation state in HSCs via AP-1 and immediate early response genes, independent of chromatin changes.
• Targeting AP-1 rescued Kdm6b-deficient HSC function.
• Kdm6b is essential for fetal T-ALL and adult AML, but not vice versa.

Conclusions:

• KDM6B plays a critical role in HSC self-renewal and stress response.
• KDM6B regulates AP-1 complex activity during HSC stress.
• KDM6B is context-dependently required for leukemogenesis.
• KDM6B represents a promising therapeutic target for specific hematopoietic malignancies.